Cancer care is costly for individuals and in the aggregate. In one study, insured patients with advanced cancer reported median monthly out-of-pocket treatment expenditures of $592. In the aggregate, US expenditures for cancer care were $127 billion in 2013, which was 7% of total health care expenditures. These costs are projected to be at least $158 billion in 2020. Cancer care contributed 6.5% of the growth in health expenditures from 2000 to 2013. Circulatory diseases provide an informative contrast: disability-adjusted life-years have shrunk nearly 20% from 2005 to 2010 while annual expenditures have increased 7%. For cancer, the same figures are 12% and 26%, respectively.
http://ift.tt/2yP4XSH
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: June 2018 Source: Acta Biomaterialia, Volume 73 https://ift.tt/2kBbISt
-
Publication date: Available online 22 March 2017 Source: Vaccine Author(s): Yanli Yang, Qizu Zhao, Zhengjun Li, Lijing Sun, Guanghui Ma,...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου